Entering text into the input field will update the search result below

Valeant sets Q1 earning call for June 7

  • Valeant Pharmaceuticals (VRX) sets June 7 at 8:00 am ET for its conference call to discuss Q1 results. Consensus view is EPS of $1.38 on revenues of $2.39B.

Recommended For You

Related Stocks

SymbolLast Price% Chg
BHC
--
BHC:CA
--